
MedTech firm pioneering a subcutaneous blood pressure monitor for uncontrolled hypertension.
Founded with a mission to empower patients and clinicians through actionable insights, CoraVie Medical is a MedTech firm focused on preventing the progression of cardiovascular disease. The company is pioneering the development of a subcutaneous continuous blood pressure monitor specifically designed for patients with uncontrolled hypertension. This innovative device aims to provide real-time data to help manage and mitigate the risks associated with high blood pressure, targeting a critical need in the healthcare market.
CoraVie Medical has garnered attention from notable investors and industry experts due to its groundbreaking approach to blood pressure monitoring. The company's key achievements include successful early-stage development and positive preliminary feedback from clinical trials. By offering a continuous monitoring solution, CoraVie Medical is poised to make a significant impact on the management of cardiovascular health, potentially reducing the incidence of heart-related complications and improving patient outcomes.

Corinnova
corinnova.com

Dynocardia
dynocardia.care

Caretaker Medical

Vivifi Medical
vivifimedical.com

Early Bird Medical
earlybirdmed.com

Qura
qura.biz

AtaCor Medical
atacor.com

CardieX
cardiex.com

Viacor

Compact Medical

Vixiar Medical
vixiar.com

Flow Medical
flowmedical.co

4C Medical Technologies
4cmed.com

Renata Medical
renatamedical.com

Atrility Medical
atrility.com
Companies similar to CoraVie Medical include Corinnova, Dynocardia, Caretaker Medical and Vivifi Medical.
CoraVie Medical was founded in 2020.
CoraVie Medical's headquarters is located in Minneapolis, MN, US.
CoraVie Medical's most recent funding round was for $275k (USD) in July 2022.
As of Jul 29, 2022, CoraVie Medical has raised a total of $2M (USD).
CoraVie Medical has 9 employees as of Feb 4, 2024.